On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...

Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk NVO revealed 11 unusual trades. Delving into the details, we found 72% of ...

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...